Kaleido Biosciences, Inc is a biotechnology business based in the US. Kaleido Biosciences shares (KLDO) are listed on the NASDAQ and all prices are listed in US Dollars. Kaleido Biosciences employs 82 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Kaleido Biosciences
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – KLDO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Kaleido Biosciences stock price (NASDAQ: KLDO)Use our graph to track the performance of KLDO stocks over time.
Kaleido Biosciences shares at a glance
|Latest market close||$7.18|
|52-week range||$5.04 - $16.93|
|50-day moving average||$7.07|
|200-day moving average||$8.65|
|Wall St. target price||$17.83|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-6.24|
Buy Kaleido Biosciences shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Kaleido Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Kaleido Biosciences price performance over time
|1 week (2021-07-23)||N/A|
|1 month (2021-07-02)||-9.23%|
|3 months (2021-05-03)||-2.45%|
|6 months (2021-01-30)||N/A|
|1 year (2020-07-30)||N/A|
|2 years (2019-07-30)||N/A|
|3 years (2018-07-30)||N/A|
|5 years (2016-07-30)||N/A|
Kaleido Biosciences financials
|Revenue TTM||$1.3 million|
|Gross profit TTM||$-54,992,000|
|Return on assets TTM||-59.77%|
|Return on equity TTM||-161.51%|
|Market capitalisation||$250 million|
TTM: trailing 12 months
Shorting Kaleido Biosciences shares
There are currently 3.5 million Kaleido Biosciences shares held short by investors – that's known as Kaleido Biosciences's "short interest". This figure is 1.2% up from 3.4 million last month.
There are a few different ways that this level of interest in shorting Kaleido Biosciences shares can be evaluated.
Kaleido Biosciences's "short interest ratio" (SIR)
Kaleido Biosciences's "short interest ratio" (SIR) is the quantity of Kaleido Biosciences shares currently shorted divided by the average quantity of Kaleido Biosciences shares traded daily (recently around 467492.02702703). Kaleido Biosciences's SIR currently stands at 7.4. In other words for every 100,000 Kaleido Biosciences shares traded daily on the market, roughly 7400 shares are currently held short.
However Kaleido Biosciences's short interest can also be evaluated against the total number of Kaleido Biosciences shares, or, against the total number of tradable Kaleido Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Kaleido Biosciences's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Kaleido Biosciences shares in existence, roughly 80 shares are currently held short) or 0.1652% of the tradable shares (for every 100,000 tradable Kaleido Biosciences shares, roughly 165 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Kaleido Biosciences.
Find out more about how you can short Kaleido Biosciences stock.
Kaleido Biosciences share dividends
We're not expecting Kaleido Biosciences to pay a dividend over the next 12 months.
Kaleido Biosciences share price volatility
Over the last 12 months, Kaleido Biosciences's shares have ranged in value from as little as $5.04 up to $16.929. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Kaleido Biosciences's is -0.3163. This would suggest that Kaleido Biosciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Kaleido Biosciences has bucked the trend.
Kaleido Biosciences overview
Kaleido Biosciences, Inc. , a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of immuno-oncology, and cardiometabolic and liver diseases. The company has collaboration agreements with Gustave Roussy Cancer Center, Washington University School of Medicine, and Janssen. The company was incorporated in 2015 and is headquartered in Lexington, Massachusetts. .
Stocks similar to Kaleido Biosciences
Kaleido Biosciences in the news
Kaleido Biosciences, Inc. (KLDO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
61 Biggest Movers From Yesterday
38 Stocks Moving In Thursday's Mid-Day Session
Frequently asked questionsWhat percentage of Kaleido Biosciences is owned by insiders or institutions?
Currently 4.72% of Kaleido Biosciences shares are held by insiders and 80.917% by institutions. How many people work for Kaleido Biosciences?
Latest data suggests 82 work at Kaleido Biosciences. When does the fiscal year end for Kaleido Biosciences?
Kaleido Biosciences's fiscal year ends in December. Where is Kaleido Biosciences based?
Kaleido Biosciences's address is: 65 Hayden Avenue, Lexington, MA, United States, 02421 What is Kaleido Biosciences's ISIN number?
Kaleido Biosciences's international securities identification number is: US4833471000 What is Kaleido Biosciences's CUSIP number?
Kaleido Biosciences's Committee on Uniform Securities Identification Procedures number is: 483347100
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert